Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy

Conditions

• Homozygous Familial Hypercholesterolemia

Interventions

• DRUG: Lomitapide

Sponsor

Aegerion Pharmaceuticals, Inc.